nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A4—bone cancer	0.897	1	CbGaD
Salmeterol—Salbutamol—CYP3A4—bone cancer	0.00133	0.641	CrCbGaD
Salmeterol—Propafenone—CYP3A4—bone cancer	0.00074	0.358	CrCbGaD
Salmeterol—Abdominal discomfort—Cisplatin—bone cancer	0.000712	0.00702	CcSEcCtD
Salmeterol—Vasodilation procedure—Epirubicin—bone cancer	0.000692	0.00682	CcSEcCtD
Salmeterol—Vasodilation—Epirubicin—bone cancer	0.000692	0.00682	CcSEcCtD
Salmeterol—Dysphonia—Doxorubicin—bone cancer	0.000684	0.00674	CcSEcCtD
Salmeterol—Viral infection—Epirubicin—bone cancer	0.000673	0.00663	CcSEcCtD
Salmeterol—Inflammation—Methotrexate—bone cancer	0.00067	0.0066	CcSEcCtD
Salmeterol—Conjunctivitis—Cisplatin—bone cancer	0.000644	0.00634	CcSEcCtD
Salmeterol—Vasodilation—Doxorubicin—bone cancer	0.000641	0.00631	CcSEcCtD
Salmeterol—Vasodilation procedure—Doxorubicin—bone cancer	0.000641	0.00631	CcSEcCtD
Salmeterol—Bone pain—Epirubicin—bone cancer	0.000635	0.00626	CcSEcCtD
Salmeterol—Inflammation—Epirubicin—bone cancer	0.000627	0.00618	CcSEcCtD
Salmeterol—Viral infection—Doxorubicin—bone cancer	0.000623	0.00614	CcSEcCtD
Salmeterol—Musculoskeletal pain—Epirubicin—bone cancer	0.000616	0.00606	CcSEcCtD
Salmeterol—Neck pain—Epirubicin—bone cancer	0.000616	0.00606	CcSEcCtD
Salmeterol—Ventricular tachycardia—Epirubicin—bone cancer	0.000608	0.00599	CcSEcCtD
Salmeterol—Dermatitis contact—Epirubicin—bone cancer	0.000601	0.00592	CcSEcCtD
Salmeterol—Bone pain—Doxorubicin—bone cancer	0.000587	0.00579	CcSEcCtD
Salmeterol—Connective tissue disorder—Cisplatin—bone cancer	0.000584	0.00576	CcSEcCtD
Salmeterol—Candida infection—Epirubicin—bone cancer	0.000581	0.00572	CcSEcCtD
Salmeterol—Inflammation—Doxorubicin—bone cancer	0.00058	0.00572	CcSEcCtD
Salmeterol—Neck pain—Doxorubicin—bone cancer	0.00057	0.00561	CcSEcCtD
Salmeterol—Musculoskeletal pain—Doxorubicin—bone cancer	0.00057	0.00561	CcSEcCtD
Salmeterol—Ventricular tachycardia—Doxorubicin—bone cancer	0.000563	0.00554	CcSEcCtD
Salmeterol—Cramps of lower extremities—Epirubicin—bone cancer	0.000559	0.0055	CcSEcCtD
Salmeterol—Dermatitis contact—Doxorubicin—bone cancer	0.000556	0.00548	CcSEcCtD
Salmeterol—Cardiac disorder—Cisplatin—bone cancer	0.000552	0.00544	CcSEcCtD
Salmeterol—Candida infection—Doxorubicin—bone cancer	0.000537	0.00529	CcSEcCtD
Salmeterol—Immune system disorder—Cisplatin—bone cancer	0.000537	0.00529	CcSEcCtD
Salmeterol—Mediastinal disorder—Cisplatin—bone cancer	0.000536	0.00528	CcSEcCtD
Salmeterol—Arrhythmia—Cisplatin—bone cancer	0.000531	0.00523	CcSEcCtD
Salmeterol—Malnutrition—Cisplatin—bone cancer	0.000518	0.0051	CcSEcCtD
Salmeterol—Cramps of lower extremities—Doxorubicin—bone cancer	0.000517	0.00509	CcSEcCtD
Salmeterol—Muscle spasms—Cisplatin—bone cancer	0.000498	0.0049	CcSEcCtD
Salmeterol—Eczema—Epirubicin—bone cancer	0.000491	0.00484	CcSEcCtD
Salmeterol—Tremor—Cisplatin—bone cancer	0.000485	0.00478	CcSEcCtD
Salmeterol—Ill-defined disorder—Cisplatin—bone cancer	0.00048	0.00473	CcSEcCtD
Salmeterol—Malaise—Cisplatin—bone cancer	0.000467	0.0046	CcSEcCtD
Salmeterol—Eczema—Doxorubicin—bone cancer	0.000455	0.00448	CcSEcCtD
Salmeterol—Irritability—Methotrexate—bone cancer	0.00045	0.00444	CcSEcCtD
Salmeterol—Pain in extremity—Epirubicin—bone cancer	0.000442	0.00435	CcSEcCtD
Salmeterol—Myalgia—Cisplatin—bone cancer	0.000441	0.00434	CcSEcCtD
Salmeterol—Anxiety—Cisplatin—bone cancer	0.000439	0.00433	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000438	0.00431	CcSEcCtD
Salmeterol—Discomfort—Cisplatin—bone cancer	0.000436	0.00429	CcSEcCtD
Salmeterol—Migraine—Epirubicin—bone cancer	0.000435	0.00428	CcSEcCtD
Salmeterol—Anaphylactic shock—Cisplatin—bone cancer	0.000423	0.00416	CcSEcCtD
Salmeterol—Oedema—Cisplatin—bone cancer	0.000423	0.00416	CcSEcCtD
Salmeterol—Infection—Cisplatin—bone cancer	0.00042	0.00414	CcSEcCtD
Salmeterol—Nervous system disorder—Cisplatin—bone cancer	0.000414	0.00408	CcSEcCtD
Salmeterol—Tachycardia—Cisplatin—bone cancer	0.000412	0.00406	CcSEcCtD
Salmeterol—Skin disorder—Cisplatin—bone cancer	0.00041	0.00404	CcSEcCtD
Salmeterol—Pain in extremity—Doxorubicin—bone cancer	0.000409	0.00402	CcSEcCtD
Salmeterol—Asthma—Methotrexate—bone cancer	0.000408	0.00402	CcSEcCtD
Salmeterol—Abdominal pain upper—Epirubicin—bone cancer	0.000403	0.00397	CcSEcCtD
Salmeterol—Migraine—Doxorubicin—bone cancer	0.000402	0.00396	CcSEcCtD
Salmeterol—Nasopharyngitis—Epirubicin—bone cancer	0.000395	0.00389	CcSEcCtD
Salmeterol—Abdominal discomfort—Methotrexate—bone cancer	0.000391	0.00385	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000385	0.00379	CcSEcCtD
Salmeterol—Asthma—Epirubicin—bone cancer	0.000382	0.00376	CcSEcCtD
Salmeterol—Influenza—Epirubicin—bone cancer	0.000382	0.00376	CcSEcCtD
Salmeterol—Paraesthesia—Cisplatin—bone cancer	0.000379	0.00374	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Methotrexate—bone cancer	0.000379	0.00373	CcSEcCtD
Salmeterol—Dyspnoea—Cisplatin—bone cancer	0.000377	0.00371	CcSEcCtD
Salmeterol—Abdominal pain upper—Doxorubicin—bone cancer	0.000373	0.00368	CcSEcCtD
Salmeterol—Bronchitis—Epirubicin—bone cancer	0.000367	0.00362	CcSEcCtD
Salmeterol—Pneumonia—Methotrexate—bone cancer	0.000366	0.0036	CcSEcCtD
Salmeterol—Nasopharyngitis—Doxorubicin—bone cancer	0.000365	0.0036	CcSEcCtD
Salmeterol—Infestation NOS—Methotrexate—bone cancer	0.000364	0.00358	CcSEcCtD
Salmeterol—Infestation—Methotrexate—bone cancer	0.000364	0.00358	CcSEcCtD
Salmeterol—Pain—Cisplatin—bone cancer	0.000361	0.00356	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Epirubicin—bone cancer	0.000355	0.00349	CcSEcCtD
Salmeterol—Conjunctivitis—Methotrexate—bone cancer	0.000353	0.00348	CcSEcCtD
Salmeterol—Influenza—Doxorubicin—bone cancer	0.000353	0.00348	CcSEcCtD
Salmeterol—Asthma—Doxorubicin—bone cancer	0.000353	0.00348	CcSEcCtD
Salmeterol—Feeling abnormal—Cisplatin—bone cancer	0.000348	0.00343	CcSEcCtD
Salmeterol—Hyperglycaemia—Epirubicin—bone cancer	0.000344	0.00339	CcSEcCtD
Salmeterol—Epistaxis—Methotrexate—bone cancer	0.000343	0.00338	CcSEcCtD
Salmeterol—Pneumonia—Epirubicin—bone cancer	0.000342	0.00337	CcSEcCtD
Salmeterol—Infestation NOS—Epirubicin—bone cancer	0.00034	0.00335	CcSEcCtD
Salmeterol—Infestation—Epirubicin—bone cancer	0.00034	0.00335	CcSEcCtD
Salmeterol—Bronchitis—Doxorubicin—bone cancer	0.00034	0.00335	CcSEcCtD
Salmeterol—Body temperature increased—Cisplatin—bone cancer	0.000334	0.00329	CcSEcCtD
Salmeterol—Conjunctivitis—Epirubicin—bone cancer	0.000331	0.00326	CcSEcCtD
Salmeterol—Urinary tract infection—Epirubicin—bone cancer	0.000331	0.00326	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000328	0.00323	CcSEcCtD
Salmeterol—Pharyngitis—Methotrexate—bone cancer	0.000324	0.00319	CcSEcCtD
Salmeterol—Epistaxis—Epirubicin—bone cancer	0.000321	0.00316	CcSEcCtD
Salmeterol—Sinusitis—Epirubicin—bone cancer	0.000319	0.00314	CcSEcCtD
Salmeterol—Hyperglycaemia—Doxorubicin—bone cancer	0.000319	0.00314	CcSEcCtD
Salmeterol—Pneumonia—Doxorubicin—bone cancer	0.000317	0.00312	CcSEcCtD
Salmeterol—Infestation—Doxorubicin—bone cancer	0.000315	0.0031	CcSEcCtD
Salmeterol—Infestation NOS—Doxorubicin—bone cancer	0.000315	0.0031	CcSEcCtD
Salmeterol—Hypersensitivity—Cisplatin—bone cancer	0.000311	0.00307	CcSEcCtD
Salmeterol—Rhinitis—Epirubicin—bone cancer	0.000306	0.00302	CcSEcCtD
Salmeterol—Conjunctivitis—Doxorubicin—bone cancer	0.000306	0.00301	CcSEcCtD
Salmeterol—Urinary tract infection—Doxorubicin—bone cancer	0.000306	0.00301	CcSEcCtD
Salmeterol—Asthenia—Cisplatin—bone cancer	0.000303	0.00299	CcSEcCtD
Salmeterol—Pharyngitis—Epirubicin—bone cancer	0.000303	0.00299	CcSEcCtD
Salmeterol—Cardiac disorder—Methotrexate—bone cancer	0.000303	0.00298	CcSEcCtD
Salmeterol—Connective tissue disorder—Epirubicin—bone cancer	0.0003	0.00296	CcSEcCtD
Salmeterol—Epistaxis—Doxorubicin—bone cancer	0.000297	0.00293	CcSEcCtD
Salmeterol—Sinusitis—Doxorubicin—bone cancer	0.000295	0.00291	CcSEcCtD
Salmeterol—Immune system disorder—Methotrexate—bone cancer	0.000295	0.0029	CcSEcCtD
Salmeterol—Mediastinal disorder—Methotrexate—bone cancer	0.000294	0.0029	CcSEcCtD
Salmeterol—Diarrhoea—Cisplatin—bone cancer	0.000289	0.00285	CcSEcCtD
Salmeterol—Mental disorder—Methotrexate—bone cancer	0.000286	0.00282	CcSEcCtD
Salmeterol—Malnutrition—Methotrexate—bone cancer	0.000284	0.0028	CcSEcCtD
Salmeterol—Cardiac disorder—Epirubicin—bone cancer	0.000283	0.00279	CcSEcCtD
Salmeterol—Rhinitis—Doxorubicin—bone cancer	0.000283	0.00279	CcSEcCtD
Salmeterol—Pharyngitis—Doxorubicin—bone cancer	0.00028	0.00276	CcSEcCtD
Salmeterol—Connective tissue disorder—Doxorubicin—bone cancer	0.000278	0.00274	CcSEcCtD
Salmeterol—Immune system disorder—Epirubicin—bone cancer	0.000276	0.00272	CcSEcCtD
Salmeterol—Mediastinal disorder—Epirubicin—bone cancer	0.000275	0.00271	CcSEcCtD
Salmeterol—Back pain—Methotrexate—bone cancer	0.000275	0.00271	CcSEcCtD
Salmeterol—Arrhythmia—Epirubicin—bone cancer	0.000273	0.00269	CcSEcCtD
Salmeterol—Vomiting—Cisplatin—bone cancer	0.000269	0.00265	CcSEcCtD
Salmeterol—Mental disorder—Epirubicin—bone cancer	0.000268	0.00264	CcSEcCtD
Salmeterol—Rash—Cisplatin—bone cancer	0.000266	0.00262	CcSEcCtD
Salmeterol—Dermatitis—Cisplatin—bone cancer	0.000266	0.00262	CcSEcCtD
Salmeterol—Malnutrition—Epirubicin—bone cancer	0.000266	0.00262	CcSEcCtD
Salmeterol—Ill-defined disorder—Methotrexate—bone cancer	0.000264	0.0026	CcSEcCtD
Salmeterol—Cardiac disorder—Doxorubicin—bone cancer	0.000262	0.00258	CcSEcCtD
Salmeterol—Tension—Epirubicin—bone cancer	0.000261	0.00257	CcSEcCtD
Salmeterol—Nervousness—Epirubicin—bone cancer	0.000258	0.00254	CcSEcCtD
Salmeterol—Back pain—Epirubicin—bone cancer	0.000257	0.00253	CcSEcCtD
Salmeterol—Malaise—Methotrexate—bone cancer	0.000256	0.00252	CcSEcCtD
Salmeterol—Muscle spasms—Epirubicin—bone cancer	0.000256	0.00252	CcSEcCtD
Salmeterol—Immune system disorder—Doxorubicin—bone cancer	0.000255	0.00251	CcSEcCtD
Salmeterol—Mediastinal disorder—Doxorubicin—bone cancer	0.000255	0.00251	CcSEcCtD
Salmeterol—Arrhythmia—Doxorubicin—bone cancer	0.000252	0.00249	CcSEcCtD
Salmeterol—Nausea—Cisplatin—bone cancer	0.000251	0.00247	CcSEcCtD
Salmeterol—Cough—Methotrexate—bone cancer	0.000248	0.00244	CcSEcCtD
Salmeterol—Mental disorder—Doxorubicin—bone cancer	0.000248	0.00244	CcSEcCtD
Salmeterol—Ill-defined disorder—Epirubicin—bone cancer	0.000247	0.00243	CcSEcCtD
Salmeterol—Malnutrition—Doxorubicin—bone cancer	0.000246	0.00242	CcSEcCtD
Salmeterol—Agitation—Epirubicin—bone cancer	0.000244	0.00241	CcSEcCtD
Salmeterol—Arthralgia—Methotrexate—bone cancer	0.000242	0.00238	CcSEcCtD
Salmeterol—Myalgia—Methotrexate—bone cancer	0.000242	0.00238	CcSEcCtD
Salmeterol—Chest pain—Methotrexate—bone cancer	0.000242	0.00238	CcSEcCtD
Salmeterol—Tension—Doxorubicin—bone cancer	0.000241	0.00238	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00024	0.00237	CcSEcCtD
Salmeterol—Malaise—Epirubicin—bone cancer	0.00024	0.00236	CcSEcCtD
Salmeterol—Discomfort—Methotrexate—bone cancer	0.000239	0.00235	CcSEcCtD
Salmeterol—Nervousness—Doxorubicin—bone cancer	0.000239	0.00235	CcSEcCtD
Salmeterol—Back pain—Doxorubicin—bone cancer	0.000238	0.00234	CcSEcCtD
Salmeterol—Muscle spasms—Doxorubicin—bone cancer	0.000237	0.00233	CcSEcCtD
Salmeterol—Palpitations—Epirubicin—bone cancer	0.000235	0.00231	CcSEcCtD
Salmeterol—Cough—Epirubicin—bone cancer	0.000232	0.00229	CcSEcCtD
Salmeterol—Anaphylactic shock—Methotrexate—bone cancer	0.000232	0.00228	CcSEcCtD
Salmeterol—Infection—Methotrexate—bone cancer	0.00023	0.00227	CcSEcCtD
Salmeterol—Hypertension—Epirubicin—bone cancer	0.00023	0.00226	CcSEcCtD
Salmeterol—Ill-defined disorder—Doxorubicin—bone cancer	0.000228	0.00225	CcSEcCtD
Salmeterol—Nervous system disorder—Methotrexate—bone cancer	0.000227	0.00224	CcSEcCtD
Salmeterol—Arthralgia—Epirubicin—bone cancer	0.000226	0.00223	CcSEcCtD
Salmeterol—Myalgia—Epirubicin—bone cancer	0.000226	0.00223	CcSEcCtD
Salmeterol—Chest pain—Epirubicin—bone cancer	0.000226	0.00223	CcSEcCtD
Salmeterol—Agitation—Doxorubicin—bone cancer	0.000226	0.00223	CcSEcCtD
Salmeterol—Anxiety—Epirubicin—bone cancer	0.000226	0.00222	CcSEcCtD
Salmeterol—Skin disorder—Methotrexate—bone cancer	0.000225	0.00222	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000225	0.00221	CcSEcCtD
Salmeterol—Discomfort—Epirubicin—bone cancer	0.000224	0.0022	CcSEcCtD
Salmeterol—Malaise—Doxorubicin—bone cancer	0.000222	0.00219	CcSEcCtD
Salmeterol—Dry mouth—Epirubicin—bone cancer	0.000221	0.00218	CcSEcCtD
Salmeterol—Palpitations—Doxorubicin—bone cancer	0.000217	0.00214	CcSEcCtD
Salmeterol—Anaphylactic shock—Epirubicin—bone cancer	0.000217	0.00214	CcSEcCtD
Salmeterol—Oedema—Epirubicin—bone cancer	0.000217	0.00214	CcSEcCtD
Salmeterol—Infection—Epirubicin—bone cancer	0.000216	0.00212	CcSEcCtD
Salmeterol—Cough—Doxorubicin—bone cancer	0.000215	0.00211	CcSEcCtD
Salmeterol—Nervous system disorder—Epirubicin—bone cancer	0.000213	0.0021	CcSEcCtD
Salmeterol—Hypertension—Doxorubicin—bone cancer	0.000212	0.00209	CcSEcCtD
Salmeterol—Tachycardia—Epirubicin—bone cancer	0.000212	0.00209	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000211	0.00208	CcSEcCtD
Salmeterol—Skin disorder—Epirubicin—bone cancer	0.000211	0.00208	CcSEcCtD
Salmeterol—Insomnia—Methotrexate—bone cancer	0.00021	0.00207	CcSEcCtD
Salmeterol—Arthralgia—Doxorubicin—bone cancer	0.000209	0.00206	CcSEcCtD
Salmeterol—Myalgia—Doxorubicin—bone cancer	0.000209	0.00206	CcSEcCtD
Salmeterol—Chest pain—Doxorubicin—bone cancer	0.000209	0.00206	CcSEcCtD
Salmeterol—Anxiety—Doxorubicin—bone cancer	0.000209	0.00206	CcSEcCtD
Salmeterol—Paraesthesia—Methotrexate—bone cancer	0.000208	0.00205	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000208	0.00205	CcSEcCtD
Salmeterol—Discomfort—Doxorubicin—bone cancer	0.000207	0.00204	CcSEcCtD
Salmeterol—Dyspnoea—Methotrexate—bone cancer	0.000207	0.00204	CcSEcCtD
Salmeterol—Dry mouth—Doxorubicin—bone cancer	0.000205	0.00202	CcSEcCtD
Salmeterol—Dyspepsia—Methotrexate—bone cancer	0.000204	0.00201	CcSEcCtD
Salmeterol—Oedema—Doxorubicin—bone cancer	0.000201	0.00198	CcSEcCtD
Salmeterol—Anaphylactic shock—Doxorubicin—bone cancer	0.000201	0.00198	CcSEcCtD
Salmeterol—Fatigue—Methotrexate—bone cancer	0.0002	0.00197	CcSEcCtD
Salmeterol—Infection—Doxorubicin—bone cancer	0.000199	0.00197	CcSEcCtD
Salmeterol—Pain—Methotrexate—bone cancer	0.000198	0.00195	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000198	0.00195	CcSEcCtD
Salmeterol—Nervous system disorder—Doxorubicin—bone cancer	0.000197	0.00194	CcSEcCtD
Salmeterol—Insomnia—Epirubicin—bone cancer	0.000196	0.00193	CcSEcCtD
Salmeterol—Tachycardia—Doxorubicin—bone cancer	0.000196	0.00193	CcSEcCtD
Salmeterol—Skin disorder—Doxorubicin—bone cancer	0.000195	0.00192	CcSEcCtD
Salmeterol—Paraesthesia—Epirubicin—bone cancer	0.000195	0.00192	CcSEcCtD
Salmeterol—Dyspnoea—Epirubicin—bone cancer	0.000193	0.00191	CcSEcCtD
Salmeterol—Feeling abnormal—Methotrexate—bone cancer	0.000191	0.00188	CcSEcCtD
Salmeterol—Dyspepsia—Epirubicin—bone cancer	0.000191	0.00188	CcSEcCtD
Salmeterol—Gastrointestinal pain—Methotrexate—bone cancer	0.00019	0.00187	CcSEcCtD
Salmeterol—Fatigue—Epirubicin—bone cancer	0.000187	0.00184	CcSEcCtD
Salmeterol—Constipation—Epirubicin—bone cancer	0.000186	0.00183	CcSEcCtD
Salmeterol—Pain—Epirubicin—bone cancer	0.000186	0.00183	CcSEcCtD
Salmeterol—Urticaria—Methotrexate—bone cancer	0.000184	0.00181	CcSEcCtD
Salmeterol—Abdominal pain—Methotrexate—bone cancer	0.000183	0.00181	CcSEcCtD
Salmeterol—Body temperature increased—Methotrexate—bone cancer	0.000183	0.00181	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000183	0.0018	CcSEcCtD
Salmeterol—Insomnia—Doxorubicin—bone cancer	0.000182	0.00179	CcSEcCtD
Salmeterol—Paraesthesia—Doxorubicin—bone cancer	0.00018	0.00178	CcSEcCtD
Salmeterol—Dyspnoea—Doxorubicin—bone cancer	0.000179	0.00176	CcSEcCtD
Salmeterol—Feeling abnormal—Epirubicin—bone cancer	0.000179	0.00176	CcSEcCtD
Salmeterol—Gastrointestinal pain—Epirubicin—bone cancer	0.000177	0.00175	CcSEcCtD
Salmeterol—Dyspepsia—Doxorubicin—bone cancer	0.000177	0.00174	CcSEcCtD
Salmeterol—Fatigue—Doxorubicin—bone cancer	0.000173	0.00171	CcSEcCtD
Salmeterol—Urticaria—Epirubicin—bone cancer	0.000172	0.0017	CcSEcCtD
Salmeterol—Pain—Doxorubicin—bone cancer	0.000172	0.00169	CcSEcCtD
Salmeterol—Constipation—Doxorubicin—bone cancer	0.000172	0.00169	CcSEcCtD
Salmeterol—Abdominal pain—Epirubicin—bone cancer	0.000172	0.00169	CcSEcCtD
Salmeterol—Body temperature increased—Epirubicin—bone cancer	0.000172	0.00169	CcSEcCtD
Salmeterol—Hypersensitivity—Methotrexate—bone cancer	0.000171	0.00168	CcSEcCtD
Salmeterol—Asthenia—Methotrexate—bone cancer	0.000166	0.00164	CcSEcCtD
Salmeterol—Feeling abnormal—Doxorubicin—bone cancer	0.000165	0.00163	CcSEcCtD
Salmeterol—Gastrointestinal pain—Doxorubicin—bone cancer	0.000164	0.00162	CcSEcCtD
Salmeterol—Hypersensitivity—Epirubicin—bone cancer	0.00016	0.00158	CcSEcCtD
Salmeterol—Urticaria—Doxorubicin—bone cancer	0.00016	0.00157	CcSEcCtD
Salmeterol—Abdominal pain—Doxorubicin—bone cancer	0.000159	0.00156	CcSEcCtD
Salmeterol—Body temperature increased—Doxorubicin—bone cancer	0.000159	0.00156	CcSEcCtD
Salmeterol—Diarrhoea—Methotrexate—bone cancer	0.000159	0.00156	CcSEcCtD
Salmeterol—Asthenia—Epirubicin—bone cancer	0.000156	0.00153	CcSEcCtD
Salmeterol—Dizziness—Methotrexate—bone cancer	0.000153	0.00151	CcSEcCtD
Salmeterol—Diarrhoea—Epirubicin—bone cancer	0.000148	0.00146	CcSEcCtD
Salmeterol—Hypersensitivity—Doxorubicin—bone cancer	0.000148	0.00146	CcSEcCtD
Salmeterol—Vomiting—Methotrexate—bone cancer	0.000147	0.00145	CcSEcCtD
Salmeterol—Rash—Methotrexate—bone cancer	0.000146	0.00144	CcSEcCtD
Salmeterol—Dermatitis—Methotrexate—bone cancer	0.000146	0.00144	CcSEcCtD
Salmeterol—Headache—Methotrexate—bone cancer	0.000145	0.00143	CcSEcCtD
Salmeterol—Asthenia—Doxorubicin—bone cancer	0.000144	0.00142	CcSEcCtD
Salmeterol—Dizziness—Epirubicin—bone cancer	0.000144	0.00141	CcSEcCtD
Salmeterol—Vomiting—Epirubicin—bone cancer	0.000138	0.00136	CcSEcCtD
Salmeterol—Nausea—Methotrexate—bone cancer	0.000138	0.00136	CcSEcCtD
Salmeterol—Diarrhoea—Doxorubicin—bone cancer	0.000137	0.00135	CcSEcCtD
Salmeterol—Rash—Epirubicin—bone cancer	0.000137	0.00135	CcSEcCtD
Salmeterol—Dermatitis—Epirubicin—bone cancer	0.000137	0.00135	CcSEcCtD
Salmeterol—Headache—Epirubicin—bone cancer	0.000136	0.00134	CcSEcCtD
Salmeterol—Dizziness—Doxorubicin—bone cancer	0.000133	0.00131	CcSEcCtD
Salmeterol—Nausea—Epirubicin—bone cancer	0.000129	0.00127	CcSEcCtD
Salmeterol—Vomiting—Doxorubicin—bone cancer	0.000128	0.00126	CcSEcCtD
Salmeterol—Rash—Doxorubicin—bone cancer	0.000127	0.00125	CcSEcCtD
Salmeterol—Dermatitis—Doxorubicin—bone cancer	0.000126	0.00125	CcSEcCtD
Salmeterol—Headache—Doxorubicin—bone cancer	0.000126	0.00124	CcSEcCtD
Salmeterol—Nausea—Doxorubicin—bone cancer	0.000119	0.00117	CcSEcCtD
